期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (6)
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally raised alanine aminotransferase (ALT) is controversial.......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (8)
With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Muco......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (9)
Background Syphilis transmission is increasing, and precisely how Treponema pallidum is transmitted sexually from person to person is unclear. We aime......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (6)
Background A vaccine against COVID-19 is urgently needed for older adults, in whom morbidity and mortality due to the disease are increased. We aimed ......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (4)
Background Three doses of the licensed tetravalent dengue vaccine CYD-TDV (Dengvaxia, Sanofi Pasteur, Lyon France) are immunogenic and effective again......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (7)
Background In response to the COVID-19 pandemic, the UK first adopted physical distancing measures in March, 2020. Vaccines against SARS-CoV-2 became ......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (6)
Interpretation Inappropriate antibiotic prescribing was highly prevalent nationwide in China. Over half of the antibiotic prescriptions were inappropr......
期刊: LANCET INFECTIOUS DISEASES, 2021; 21 (8)
Background Although several COVID-19 vaccines have been developed so far, they will not be sufficient to meet the global demand. Development of a wide......